ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $219,659 | -1.5% | 8,648 | +57.4% | 0.08% | -8.0% |
| Q4 2022 | $222,918 | -11.9% | 5,496 | 0.0% | 0.09% | +3.5% |
| Q1 2022 | $253,000 | -37.5% | 5,496 | -10.0% | 0.08% | -29.8% |
| Q4 2021 | $405,000 | -15.1% | 6,110 | -20.0% | 0.12% | -19.3% |
| Q3 2021 | $477,000 | -24.5% | 7,635 | 0.0% | 0.15% | -23.5% |
| Q2 2021 | $632,000 | +24.9% | 7,635 | 0.0% | 0.20% | +23.3% |
| Q1 2021 | $506,000 | +4.5% | 7,635 | +21.1% | 0.16% | +1.3% |
| Q4 2020 | $484,000 | +82.0% | 6,306 | +2.0% | 0.16% | +55.4% |
| Q3 2020 | $266,000 | +0.4% | 6,184 | +0.9% | 0.10% | -5.6% |
| Q2 2020 | $265,000 | – | 6,126 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |